Eli Lilly & Co. stock underperforms Friday when compared to competitors
Shares of Eli Lilly & Co. LLY slid 4.73% to $869.58 Friday, on what proved to be an all-around positive trading session for ...
MarketWatch16d
Eli Lilly cuts price of weight-loss drug Zepbound as competition heats up
Eli Lilly & Co. said Tuesday it’s cutting the ... provider Hims & Hers Health Inc. sharply lower. Ciara Linnane is MarketWatch's investing- and corporate-news editor. She is based in New York.
Morningstar3d
Viking Therapeutics' new contract is a game changer. Here's how much money it could bring in.
Based on Eli Lilly's pricing for its Zepbound through ... Ciara Linnane This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from ...
Morningstar10d
Weight-loss-drug price war is on, as Wegovy prices cut for monthly subscribers
Novo Nordisk's offer is different from Eli Lilly's, as Lilly said a 5-milligram ... Tomi Kilgore This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is ...